Axion Cleared Of False Advertising Before Agilent Patent Trial
Ahead of a patent infringement trial set to begin next week, a Delaware federal judge has addressed false advertising claims against biotechnology firm Axion and ruled there was no genuine dispute...To view the full article, register now.
Already a subscriber? Click here to view full article